Symbol="VERA"
AssetType="Common Stock"
Name="Vera Therapeutics Inc"
Description="Vera Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immune diseases in the United States. The company is headquartered in South San Francisco, California."
CIK="1831828"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="170 HARBOR WAY, 3RD FLOOR, SOUTH SAN FRANCISCO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="784436000"
EBITDA="-90727000"
PERatio="None"
PEGRatio="None"
BookValue="3.171"
DividendPerShare="0"
DividendYield="0"
EPS="-3.52"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.407"
ReturnOnEquityTTM="-0.819"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-3.52"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="19.17"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="4.309"
EVToRevenue="-"
EVToEBITDA="-4.858"
Beta="0.328"
num_52WeekHigh="23.39"
num_52WeekLow="5.2"
num_50DayMovingAverage="16.77"
num_200DayMovingAverage="11.79"
SharesOutstanding="44318400"
DividendDate="None"
ExDividendDate="None"
symbol="VERA"
open="17.67"
high="17.89"
low="17.23"
price="17.56"
volume="193152.00"
latest_trading_day="2023-08-24"
previous_close="17.70"
change="-0.14"
change_percent="-0.7910%"
aroon_positive_momentum_days="67"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="67"
Volume_recent_avg="569390"
Change_recent_avg="0.06"
Delta_recent_avg="0.83"
Variance_recent_avg="0.42"
Change_ratio_recent_avg="0.39"
RSI_change="FALSE"
ADX_change="FALSE"

event="aroon_milestone_positive_60"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="67"
Aroon_momentum_negative="33"
image_negative_thumbnail_id_1="1105"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0138.jpeg"
image_negative_thumbnail_id_2="1089"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0122.jpeg"
image_neutral_thumbnail_id_1="530"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0069.jpeg"
image_neutral_thumbnail_id_2="587"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0012.jpeg"
image_positive_thumbnail_id_1="675"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0033.jpeg"
image_positive_thumbnail_id_2="699"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0009.jpeg"
image_professor_thumbnail_id_1="1190"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0024.jpeg"
image_professor_thumbnail_id_2="1180"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0014.jpeg"
